论文信息 - Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy - 字舞流文

Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy

H. Koblish | M. Stubbs | Q. Wang | P. Scherle | Phillip C. C. Liu | T. Burn | L. Leffet | Yanlong Li | P. Waeltz | M. Covington | M. Hansbury | Gengjie Yang | E. Yue | A. Combs | B. Douty | B. Metcalf | S. Diamond | P. Collier | G. Hollis | S. Yeleswaram | W. Yao | R. Newton | Leslie Hall | Patricia Feldman | R. Huber | Qian Wang | Xin He | Yun-long Li | A. Roberts | D. Shuey | N. Shin | K. Wang | M. Soloviev | Mingming Gao | Sybil O'Connor | R. Collins | Kamna Katiyar | Jin Lu | Sybil O’Connor